FDA approves first COVID-19 drug: antiviral remdesivir
Update: 2025-10-09
Description
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health....
This item belongs to: audio/rivet360-audio-collection.
This item has files of the following types: Archive BitTorrent, Metadata, PNG, VBR MP3
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
